HCPCS Level II
J1568
Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg
Codes near J1568
These sit next to J1568 in the CMS Level II file. All J codes
- J1559Injection, immune globulin (hizentra), 100 mg
- J1560Injection, gamma globulin, intramuscular, over 10 cc
- J1561Injection, immune globulin, (gamunex-c/gammaked), non-lyophilized (e.g., liquid), 500 mg
- J1562Injection, immune globulin (vivaglobin), 100 mg
- J1566Injection, immune globulin, intravenous, lyophilized (e.g., powder), not otherwise specified, 500 mg
- J1569Injection, immune globulin, (gammagard liquid/gammagard liquid erc), 500 mg
- J1570Injection, ganciclovir sodium, 500 mg
- J1571Injection, hepatitis b immune globulin (hepagam b), intramuscular, 0.5 ml
- J1572Injection, immune globulin, (flebogamma/flebogamma dif), intravenous, non-lyophilized (e.g., liquid), 500 mg
- J1573Injection, hepatitis b immune globulin (hepagam b), intravenous, 0.5 ml
NDC crosswalk
| NDC | Drug | Labeler | Billable units |
|---|---|---|---|
| 00069-6002-02 | Octagam | Pfizer Inc | 4 |
| 00069-6111-02 | Octagam | Pfizer Inc | 20 |
| 00069-6237-02 | Octagam | Pfizer Inc | 40 |
| 00069-6339-02 | Octagam | Pfizer Inc | 60 |
| 00069-6550-02 | Octagam | Pfizer Inc | 10 |
| 00069-8400-02 | Octagam | Pfizer Inc | 2 |
| 00069-8425-02 | Octagam | Pfizer Inc | 5 |
| 00069-8451-02 | Octagam | Pfizer Inc | 10 |
| 00069-8476-02 | Octagam | Pfizer Inc | 20 |
| 68982-0840-01 | Octagam | Octapharma USA Inc. | 2 |
| 68982-0840-02 | Octagam | Octapharma USA Inc. | 5 |
| 68982-0840-03 | Octagam | Octapharma USA Inc. | 10 |
| 68982-0840-04 | Octagam | Octapharma USA Inc. | 20 |
| 68982-0850-01 | Octagam | Octapharma USA Inc. | 4 |
| 68982-0850-02 | Octagam | Octapharma USA Inc. | 10 |
| 68982-0850-03 | Octagam | Octapharma USA Inc. | 20 |
| 68982-0850-04 | Octagam | Octapharma USA Inc. | 40 |
| 68982-0850-05 | Octagam | Octapharma USA Inc. | 60 |
Source: CMS ASP NDC-HCPCS crosswalk, effective October 1, 2026 through December 31, 2026.